Diagnose differently with BIOTIA‑ID
The next-generation of diagnostics is here. Our platform, BIOTIA–ID, uses next-generation sequencing technology paired with artificial intelligence for comprehensive pathogen detection and resistance profiling.
BIOTIA‑ID
A single test for comprehensive pathogen diagnostics
Problems we solve
Current gold standard for infectious disease diagnostics relies on antiquated technologies which yield inconsistent results.
Clinical metagenomics, and BIOTIA-ID is a next-generation sequencing platform utilizing a database of more than 7,000 pathogens to accurately and sensitively diagnose infectious disease causing pathogens.
This approach enables us to identify organisms that are difficult to culture or may not be common targets of PCR testing – empowering you as a provider to have the most comprehensive information when treating your patients.
With a quick turn around time of 36-72 hours, we can provide you the rapid answers you need to provide the best care possible for your patients.
Infectious Diseases
Biotia-ID utilizes next-generation sequencing (NGS) to be able to accurately and consistently identify pathogens known to cause an array of diseases.
Antimicrobial Resistance
BIOTIA-ID identifies antimicrobial resistance markers to improve clinical therapeutic decisions a patient health outcome.
Emerging Infections
With a rapidly evolving database of over 7,000 pathogens Biotia-ID is able to identify and flag emerging species that may be on the rise in a certain sample time.
BIOTIA‑ID Key Features
Genomics-based diagnostic assay for accurate pathogen detection of infectious diseases
Optimized therapy based on microbial profile and drug resistance
97% Sensitivity
99% Specificity
Comprehensive testing including fastidious bacteria, anaerobes, and polymicrobial infections
Continuous database, bioinformatic and ML/AI development
Learn more about our products
BIOTIA-ID for Urinary Tract Infection
BIOTIA-ID Urine Assay allows for comprehensive, sensitive, and accurate detection of urogenital pathogens.
BIOTIA-ID for Joint Infections
BIOTIA-ID Sterile Fluid Assay allows for comprehensive, sensitive, and accurate detection of key pathogens.
Collaborators & partners
Biotia has extensive experience leading clinical and research development in infectious disease diagnostics and pathogen surveillance.
We are proud of our extensive network and clinical partners ranging from prestigious academic institutions and medical centers, clinics, health organizations to physician groups.
"Improve patient outcomes and reduce hospital costs with one single test."
